General anesthetic is one of 164 small molecule programs targeting Neurotoxicity. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
85 competitors in Cognition
Duragesic
Accutane
Xarelto
Neurontin
Ambien
Osmitrol
Namenda
Nuplazid
Remimazolam Tosilate
Psilocybin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details